(Q35644115)

9 August 2017

1 reference

title

Ondansetron and related 5-HT3 antagonists: recent advances (English)

1 reference

9 August 2017

A. W. Oxford

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475371

30 September 2022

J. A. Bell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475371

30 September 2022

G. J. Kilpatrick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475371

30 September 2022

S. J. Ireland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475371

30 September 2022

M. B. Tyers

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1475371

30 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1475371

30 September 2022

publication date

1 January 1992

1 reference

Progress in medicinal chemistry

9 August 2017

published in

1 reference

9 August 2017

volume

29

1 reference

9 August 2017

page(s)

239-270

1 reference

10.1016/S0079-6468(08)70010-9

9 August 2017

Identifiers

DOI

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1475371

30 September 2022

1 reference